These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21108325)

  • 1. Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: a phase 2a study.
    Paul C; Sans B; Suarez F; Casassus P; Barete S; Lanternier F; Grandpeix-Guyodo C; Dubreuil P; Palmérini F; Mansfield CD; Gineste P; Moussy A; Hermine O; Lortholary O
    Am J Hematol; 2010 Dec; 85(12):921-5. PubMed ID: 21108325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study.
    Lortholary O; Chandesris MO; Bulai Livideanu C; Paul C; Guillet G; Jassem E; Niedoszytko M; Barete S; Verstovsek S; Grattan C; Damaj G; Canioni D; Fraitag S; Lhermitte L; Georgin Lavialle S; Frenzel L; Afrin LB; Hanssens K; Agopian J; Gaillard R; Kinet JP; Auclair C; Mansfield C; Moussy A; Dubreuil P; Hermine O
    Lancet; 2017 Feb; 389(10069):612-620. PubMed ID: 28069279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mastocytosis: revisited with new cytogenetic data].
    Vaes M; Vereecken P; de Wind R; Andry G; Li R; Bron D
    Rev Med Brux; 2012; 33(1):12-21. PubMed ID: 22512145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST).
    Le Cesne A; Blay JY; Bui BN; Bouché O; Adenis A; Domont J; Cioffi A; Ray-Coquard I; Lassau N; Bonvalot S; Moussy A; Kinet JP; Hermine O
    Eur J Cancer; 2010 May; 46(8):1344-51. PubMed ID: 20211560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide in systemic mastocytosis: results from an open-label, multicentre, phase II study.
    Gruson B; Lortholary O; Canioni D; Chandesris O; Lanternier F; Bruneau J; Grosbois B; Livideanu C; Larroche C; Durieu I; Barete S; Sevestre H; Diouf M; Chaby G; Marolleau JP; Dubreuil P; Hermine O; Damaj G
    Br J Haematol; 2013 May; 161(3):434-42. PubMed ID: 23432617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study.
    Tebib J; Mariette X; Bourgeois P; Flipo RM; Gaudin P; Le Loët X; Gineste P; Guy L; Mansfield CD; Moussy A; Dubreuil P; Hermine O; Sibilia J
    Arthritis Res Ther; 2009; 11(3):R95. PubMed ID: 19549290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mastocytosis and anaesthesia].
    Dewachter P; Mouton-Faivre C; Cazalaà JB; Carli P; Lortholary O; Hermine O
    Ann Fr Anesth Reanim; 2009 Jan; 28(1):61-73. PubMed ID: 19097849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature.
    Pardanani A; Tefferi A
    Curr Opin Hematol; 2010 Mar; 17(2):125-32. PubMed ID: 20075725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Most common clinical presentations of cutaneous mastocytosis.
    Bulat V; Mihić LL; Situm M; Buljan M; Blajić I; Pusić J
    Acta Clin Croat; 2009 Mar; 48(1):59-64. PubMed ID: 19623875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interest of interferon alpha in systemic mastocytosis. The French experience and review of the literature.
    Simon J; Lortholary O; Caillat-Vigneron N; Raphaël M; Martin A; Brière J; Barète S; Hermine O; Casassus P;
    Pathol Biol (Paris); 2004 Jun; 52(5):294-9. PubMed ID: 15217717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of systemic mastocytosis with high-dose interferon-alfa: long-term follow-up of a case.
    Butterfield JH; Tefferi A; Kozuh GF
    Leuk Res; 2005 Feb; 29(2):131-4. PubMed ID: 15607359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V.
    Böhm A; Sonneck K; Gleixner KV; Schuch K; Pickl WF; Blatt K; Peter B; Herrmann H; Schernthaner GH; Pehamberger H; Rabitsch W; Sperr WR; Valent P
    Exp Hematol; 2010 Sep; 38(9):744-55. PubMed ID: 20553795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.
    Alvarez-Twose I; González de Olano D; Sánchez-Muñoz L; Matito A; Esteban-López MI; Vega A; Mateo MB; Alonso Díaz de Durana MD; de la Hoz B; Del Pozo Gil MD; Caballero T; Rosado A; Sánchez Matas I; Teodósio C; Jara-Acevedo M; Mollejo M; García-Montero A; Orfao A; Escribano L
    J Allergy Clin Immunol; 2010 Jun; 125(6):1269-1278.e2. PubMed ID: 20434205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mastocytosis--a disease with many faces. Investigation and treatment should be performed in consultation with Karolinska University Hospital].
    Hägglund H; Gülen T; Sääf M; Sander B; Nilsson G
    Lakartidningen; 2008 Nov 12-18; 105(46):3341-4, 3346-7. PubMed ID: 19062626
    [No Abstract]   [Full Text] [Related]  

  • 17. Type Ib indolent mastocytosis with systemic involvement: cutaneous mastocytosis and gastrointestinal involvement at young girl.
    Georgescu EF; Stănescu L; Georgescu CV; Georgescu I
    Rom J Morphol Embryol; 2008; 49(4):547-52. PubMed ID: 19050805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anesthesia in children with mastocytosis--a case based review.
    Ahmad N; Evans P; Lloyd-Thomas AR
    Paediatr Anaesth; 2009 Feb; 19(2):97-107. PubMed ID: 19207896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients.
    Brockow K; Jofer C; Behrendt H; Ring J
    Allergy; 2008 Feb; 63(2):226-32. PubMed ID: 18186813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.